About this trial
This study is a randomized controlled trial, taking place at the University Hospital Basel (CH). It aims at the alleviation of breast cancer patients' life quality during chemotherapy.
The intervention group will participate in 10 sessions of structured hypnotherapy during the course of chemotherapy in addition to the standard of care. The control group will have access to the standard of care without any additional treatment. The main goal of the study is to investigate whether quality of life is higher among patients in the intervention group. Additionally, it will be analyzed if the interventions have a positive effect on chemotherapy side effects, symptoms of anxiety and depression and the immune system. Finally, the relative dose intensity (RDI) as well as treatment schedule adherence will be assessed.
There are no risks to be expected from the intervention itself. In the case of positive findings, the standard of psycho-oncological care can be updated by integrating structured hypnotherapeutic interventions into the treatment of patients with breast cancer.
Eligibility criteria
Qualifiers
Minimum Age 18 years
Female
Primary breast cancer
Receiving neo-adjuvant or adjuvant chemotherapy
Disqualifiers
Verbal or cognitive deficits that are not compatible with outpatient psychotherapy
Not consenting patients and vulnerable persons
Psychological disorders that prevent patients from participating in the study (e.g. psychotic disorder)
acute suicidality
Trial design
Treatments tested in this trial
- Structured Hypnotherapy
Treatment groups
Locations
1Sponsors and collaborators
Christian Schwegler
Lead sponsor
University Hospital, Basel, Switzerland
Sponsor institution